Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension: A case report with 8 years follow-up

por Deibert, Peter, Lazaro, Adhara, Stankovic, Zoran, Schaffner, Denise, Rössle, Martin, Kreisel, Wolfgang
Publicado 2018

Phosphodiesterases in the Liver as Potential Therapeutic Targets of Cirrhotic Portal Hypertension

por Kreisel, Wolfgang, Schaffner, Denise, Lazaro, Adhara, Trebicka, Jonel, Merfort, Irmgard, Schmitt-Graeff, Annette, Deibert, Peter
Publicado 2020

The impact of a weight reduction program with and without meal-replacement on health related quality of life in middle-aged obese females

por Koohkan, Sadaf, Schaffner, Denise, Milliron, Brandy J, Frey, Ingrid, König, Daniel, Deibert, Peter, Vitolins, Mara, Berg, Aloys
Publicado 2014

Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis

por Deibert, Peter, Lazaro, Adhara, Schaffner, Denise, Berg, Aloys, Koenig, Daniel, Kreisel, Wolfgang, Baumstark, Manfred W, Steinmann, Daniel, Buechert, Martin, Lange, Thomas
Publicado 2019

Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension

por Schaffner, Denise, Lazaro, Adhara, Deibert, Peter, Hasselblatt, Peter, Stoll, Patrick, Fauth, Lisa, Baumstark, Manfred W, Merfort, Irmgard, Schmitt-Graeff, Annette, Kreisel, Wolfgang
Publicado 2018